Amazing session on “Advances and novel perspective in MR antagonism” by Dr. Adler from Brigham and Women’s Endocrinology,Dr. Chimel @barrera_lab and Dr. Biwer Lauren A. Biwer, PhD from Tufts Medical Center Last session at #ENDO2022 and it could not have been better. Endocrine Society #cardiovascularendocrinology

Recent months have been exciting for the nephrology community due to results of large clinical trials showing benefit of SGLT2is and MRAs against cardiorenal outcomes. New #ClinSci review @barrera_lab et al. discuss current evidence and future directions doi.org/10.1042/CS2022…

Spreading the news of how #MatricellularProteins are important in tissue #ECMatrix remodelling processes using #SMOC2 and #RenalCellCarcinoma as our example. It was a great team effort worth being recognized in a wonderful journal #CellDeathDisease doi.org/10.1038/s41419…

#WorldKidneyDay2023 #KidneyHealthForAll 8 golden rules for healthy kidneys!

Our review on MR antagonists in DKD 👇👇🤓

Check out our new paper on the renal inflammatory effects of chronic oral tungsten exposure!! Thanks CasGerarduzzi Nathalie Henley @schrodingercen1 @pmgeraldes Michael Grant and Vincent Pichette!

Now in JASN_News. Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Contr… pubmed.ncbi.nlm.nih.gov/37428955/

Your kidneys are amazing organs and work really hard for you! Each roughly the size of your fist, kidneys are located deep in the abdomen, beneath the rib cage. Learn more about your amazing kidneys : worldkidneyday.org/about-kidney-h… #WorldKidneyDay #KidneyHealthForAll

We are extremely pleased to publish this Consensus Statement from Int Society of Nephrology, ERA - European Renal Association and American Society of Nephrology, and supported by regional societies, advocating for the recognition of kidney disease as a major #NCD driver of premature mortality. World Health Organization (WHO) go.nature.com/3U3Ll8f

Semaglutide with 24% reduction in on Kidney outcomes in Patients with Type 2 Diabetes | ⁦NEJM⁩ the FLOW trial nejm.org/doi/full/10.10…

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in NEJM nejm.org/doi/full/10.10…

1/16) We are excited to share our recent paper “ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts” published today @Jclinicalinvest led by Konrad Hoeft and Lars Koch jci.org/articles/view/…

🚨 PhD Opportunity 🚨 Passionate about #renaldiseases (#CKD #AKI), acute #inflammation, cellular #senescence, & #fibrosis? Join our team to uncover the molecular pathways driving kidney injury & discover therapeutic 🎯s 🧬 Details in 🧵👇

Presented at #KidneyWk: Two years of empagliflozin slowed kidney disease progression or cardiovascular death. In a post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation. Full post-trial study results: nej.md/3NE3W7K

Free scientific illustrations for biologists! 😍 NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations! all freely available in the public domain. Retweet and spread the message! bioart.niaid.nih.gov

Mineralocorticoid receptor antagonism for non-diabetic kidney disease 🔓doi.org/10.1093/ndt/gf…

Upcoming drug targets for kidney protective effects in chronic kidney disease 🆓doi.org/10.1093/ndt/gf…

Kidney disease often develops silently, with no early symptoms. If you are at risk, regular checks are key for early detection and management. #WorldKidneyDay 2025 focuses on detecting kidney disease early. #AreYourKidneysOK ❓ Take the quiz: kidneyquiz.theisn.org

Your kidneys are incredible organs that work tirelessly for you! About the size of a fist, they are located deep in your abdomen, just below the rib cage. Explore more about kidney health topics 👉 worldkidneyday.org/about-kidney-h… #WorldKidneyDay #AreYourKidneysOK #KidneyHealthMatters

The power of science 🤯!!